NCT03609606View on ClinicalTrials.gov

A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

August 9, 2018

Primary Completion Date

September 14, 2018

Study Completion Date

September 27, 2018

Conditions
DyslipidemiasHypertension
Interventions
DRUG

D013, D326 and D337

Daily oral administration of 1 tablet for each drug under fasting conditions for 7 days

DRUG

D013

Daily oral administration of 1 tablet under fasting conditions for 7 days

DRUG

D326 and D337

Daily oral administration of 1 tablet for each drug under fasting conditions for 7 days

Trial Locations (1)

Unknown

Korea University Anam Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT03609606 - A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter